TABLE 4. Incidence of CIN: Subgroups of Patients Without and With Diabetes Mellitus

Subgroups and PostdoseIopamidol-370 GroupIodixanol-320 GroupAbsolute Difference (95% CI)P*
Nn (%)Nn (%)
*Fisher exact test.
Patients without diabetes mellitus
    Increase of >0.5 mg/dL in SCr1265 (4.0)1182 (1.7)2.3 (−1.9 to 6.4)0.45
    Increase of >25% in SCr12612 (9.5)11812 (10.2)−0.7 (−8.1 to 6.8)1.00
    Decrease of >25% in eGFR1267 (5.6)1189 (7.6)−2.0 (−8.3 to 4.2)0.61
Patients with diabetes mellitus
    Increase of >0.5 mg/dL in SCr784 (5.1)9212 (13.0)−7.9 (−16.4 to 0.5)0.11
    Increase of >25% in SCr788 (10.3)9214 (15.2)−4.9 (−14.9 to 5.0)0.37
    Decrease of >25% in eGFR785 (6.4)9212 (13.0)−6.6 (−15.4 to 2.1)0.20